학술논문
The comparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma: A target trial emulation
Document Type
Abstract
Author
Source
In The Journal of Allergy and Clinical Immunology February 2023 151(2) Supplement:AB19-AB19
Subject
Language
ISSN
0091-6749